Company: CRVO
Filing Date: 2025-05-12
Form Type: 424B5
Source: 0001437749-25-016167
Chunk: 45

Company: CervoMed Inc.
Filing Date: 2025-05-12
Form: 424B5
Chunk 45
---
ures or to appoint a receiver or trustee, or to seek other remedies if:

| • | the holder previously has given written notice to the debenture trustee of a continuing event of default with respect to that series; |

| • | the holders of at least a majority in aggregate principal amount of the outstanding Debt Securities of that series have made written request, and such holders have offered reasonable indemnity to the debenture trustee to institute the proceeding as trustee; and |

| • | the debenture trustee does not institute the proceeding, and does not receive from the holders of a majority in aggregate principal amount of the outstanding Debt Securities of that series (or at a meeting of holders of such series at which a quorum is present, the holders of a majority in principal amount of the Debt Securities of such series represented at such meeting) other conflicting directions within 60 days after the notice, request and offer. |

These limitations do not apply to a suit instituted by a holder of Debt Securities if we default in the payment of the principal, premium, if any, or interest on, the Debt Securities. We will periodically file statements with the applicable debenture trustee regarding our compliance with specified covenants in the applicable Indenture.

Modification of Indenture; Waiver

The debenture trustee and we may change the applicable Indenture without the consent of any holders with respect to specific matters, including:

| • | to fix any ambiguity, defect or inconsistency in the Indenture; and |

<div align='center'>14</div>

| • | to change anything that does not materially adversely affect the interests of any holder of Debt Securities of any series issued pursuant to such Indenture. |

In addition, under the Indentures, the rights of holders of a series of Debt Securities may be changed by us and the debenture trustee with the written consent of the holders of at least a majority in aggregate principal amount of the outstanding Debt Securities of each series (or, at a meeting of holders of such series at which a quorum is present, the holders of a majority in principal amount of the Debt Securities of such series represented at such meeting) that is affected. However, the debenture trustee and we may make the following changes only with the consent of each holder of any outstanding Debt Securities affected:

| • | extending the fixed maturity of the series of Debt Securities; |

| • | reducing the principal amount, reducing the rate of or extending the time of payment of interest, or any premium payable